Human Genome Sciences, Inc. Asks FDA to Approve Anthrax Drug ABthrax
Published: May 21, 2009
AP -- Human Genome Sciences Inc. said Thursday it asked the Food and Drug Administration to approve ABthrax, a drug it is developing to treat inhaled anthrax.